Andere Kunden interessierten sich auch für
![Vaccine therapy of colorectal cancer patients with tumor antigens]( "Vaccine therapy of colorectal cancer patients with tumor antigens")
Vaccine therapy of colorectal cancer patients with tumor antigens42,99 €![Immunological Disorders of the oral cavity]( "Immunological Disorders of the oral cavity")
Immunological Disorders of the oral cavity43,99 €![Identification and characterization of antigens of Malarial parasites]( "Identification and characterization of antigens of Malarial parasites")
Identification and characterization of antigens of Malarial parasites42,99 €![Urinary circulating antigens of schistosomes in Gezira-Sudan]( "Urinary circulating antigens of schistosomes in Gezira-Sudan")
Urinary circulating antigens of schistosomes in Gezira-Sudan35,99 €![The value of immunological studies in the diagnosis of LGMD2]( "The value of immunological studies in the diagnosis of LGMD2")
The value of immunological studies in the diagnosis of LGMD232,99 €![Immunological Approaches to the Diagnosis and Therapy of Breast Cancer]( "Immunological Approaches to the Diagnosis and Therapy of Breast Cancer")
Immunological Approaches to the Diagnosis and Therapy of Breast Cancer74,99 €![The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging]( "The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging")
The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging42,99 €
Incidence of breast cancer is increasing worldwide and tumour markers are widely recognized as important tools in the evaluation and management of patients with cancer but additional biomarkers relevant to developing countries will provide additional support. This study evaluated the detection, diagnosis and prognostic potentials of biomarkers such as circulating immune complexes (CIC), cancer antigens (CA15-3 and CA 27.29), immunoglobulins (IgG, IgM and IgA) and pro-inflammatory cytokines (TNF- and IL-1) in patients with malignant and benign breast tumours. A total of 42 treatment-naïve female patients that presented with breast tumour were prospectively studied (pre and post-treatment).Overall, tumour of all forms recorded significantly higher pre-treatment mean values for CA 15-3 and CA 27.29 which decreased after treatment. On the contrary, therapeutic interventions did not significantly affect the mean values for CIC, IgM, IgG, IgA and pro-inflammatory cytokines. CA 15-3 andCA 27.29 presented promising diagnostic and prognostic potentials in breast cancers. Immunoglobulins, CIC and pro-inflammatory cytokines appeared to be of limited diagnostic value in our environment.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.